Role of genetic factors in imatinib resistance of chronic myeloid leukemia: P53, RB1, ASS1 gene deletions, and chromosome 8 hyperdiploidy.

Pathology, research and practice2025Hasanova A, Asadov C, Shirinova A, et al.

Study designOther primary literature

SubjectHuman

Record checks

Study design: Other primary literature
Subject: Human
Publication year: 2025
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 13 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultAgedAged, 80 and overAntineoplastic AgentsChromosomes, Human, Pair 8Drug Resistance, NeoplasmFemaleGene DeletionHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedRetinoblastoma Binding ProteinsTumor Suppressor Protein p53Ubiquitin-Protein LigasesYoung Adult

DOI 10.1016/j.prp.2025.155943

PMID 40156964

View source →